Italian registry and biobank for ML patients
Part of Blood & lymphatic, Cancer, Genetic & congenital clinical trials.
This study creates a national registry and biobank to collect medical information and biological samples from people with any type of ML, helping research into the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 0 and 100 years old.
- You or your legal guardian must sign a consent form agreeing to participate.
- You must have any form of ML, whether it is isolated, syndromic, congenital, or acquired, with or without a confirmed genetic cause.
- Your diagnosis must be confirmed by a participating center.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study enrolls people with certain lymphatic (lymph fluid) conditions to collect information and track how they do over time. It may help doctors better understand outcomes and improve care.
This study follows people who have lymphatic anomalies (lymphatic birthmarks) and sometimes related vascular or genetic conditions. It aims to better understand how these problems develop and what genetic causes may be involved.
This is a study that looks back and forward at people diagnosed with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or a related early condition called MBL. It aims to improve how these conditions are recognized and managed over time in Italy.
This study collects information from patients with lymphoproliferative disorders—conditions affecting blood and lymph cells—to help doctors better understand these diseases and improve care. Your medical records and information may be used to support research that could benefit future patients.
This study is for adults newly diagnosed with lymphoma in the last 3 months, including those who may have started treatment. It aims to collect information on patients in Italy.
This study is a cancer registry that collects information from people with lymphoma, Hodgkin disease, or myeloma. It helps researchers understand these cancers better by using real-world patient data.
Hear when a new Lymphatic Malformation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.